特宝生物
(688278)
| 流通市值：254.94亿 | | | 总市值：254.94亿 |
| 流通股本：4.07亿 | | | 总股本：4.07亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 412,956,945.26 | 525,694,947.27 | 317,421,572.18 | 520,779,757.78 |
| 应收票据及应收账款 | 441,022,155.69 | 290,335,382.85 | 351,544,124.49 | 272,328,723.49 |
| 其中：应收票据 | 3,211,662 | 909,849.8 | 1,788,766.74 | 2,767,293.99 |
| 应收账款 | 437,810,493.69 | 289,425,533.05 | 349,755,357.75 | 269,561,429.5 |
| 预付款项 | 23,389,114.21 | 26,566,379.46 | 31,673,316.66 | 16,114,962.65 |
| 其他应收款合计 | 17,800,218.99 | 36,172,757.91 | 15,894,220.26 | 12,189,351.5 |
| 其中:应收利息 | - | 87,739.73 | - | - |
| 存货 | 187,017,724.74 | 171,296,525.22 | 153,223,921.39 | 139,814,625.69 |
| 其他流动资产 | 923,793.45 | 379,983.68 | 178,600.28 | 243,960.48 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,340,191,036.92 | 1,160,609,813.02 | 900,042,796.36 | 961,471,381.59 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 37,350,684.93 | 35,000,000 | 35,000,000 | 35,000,000 |
| 固定资产 | 298,750,566.63 | 271,857,435.73 | 273,820,810.2 | 239,820,337.55 |
| 在建工程 | 183,715,136.39 | 127,921,164.59 | 128,226,696.83 | 140,881,046.15 |
| 使用权资产 | 8,387,072.11 | 9,835,980 | 10,754,265.82 | 9,348,937.29 |
| 无形资产 | 191,539,966.96 | 197,809,428.88 | 109,873,715.47 | 115,327,856.13 |
| 开发支出 | 161,110,873.96 | 220,376,785.24 | 310,303,949.22 | 252,786,212.31 |
| 长期待摊费用 | 15,590,758.66 | 19,417,690.01 | 9,028,777.56 | 7,602,391.48 |
| 递延所得税资产 | 43,662,001.45 | 42,861,275.49 | 44,528,795.11 | 44,200,663.41 |
| 其他非流动资产 | 75,788,996.16 | 51,605,706.52 | 42,247,298.68 | 38,565,360.42 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,015,896,057.25 | 976,685,466.46 | 963,784,308.89 | 883,532,804.74 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,356,087,094.17 | 2,137,295,279.48 | 1,863,827,105.25 | 1,845,004,186.33 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 40,624,624.97 | 34,300,642.51 | 59,626,939.13 | 96,736,342.22 |
| 应付账款 | 40,624,624.97 | 34,300,642.51 | 59,626,939.13 | 96,736,342.22 |
| 合同负债 | 60,053,059.95 | 59,589,065.34 | 33,361,835.97 | 4,767,855.78 |
| 应付职工薪酬 | 197,168,787.69 | 172,226,224.92 | 88,500,338.2 | 67,497,941.74 |
| 应交税费 | 65,090,483.07 | 58,091,885.29 | 36,987,001.35 | 58,631,292.48 |
| 其他应付款合计 | 36,414,615.48 | 15,330,492.72 | 21,060,073.17 | 30,077,949.11 |
| 一年内到期的非流动负债 | 4,163,351.22 | 5,135,689.81 | 5,435,414.38 | -1,049,739.02 |
| 其他流动负债 | 142,691.83 | 73,442.62 | 161,188.94 | 143,035.67 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 403,657,614.21 | 344,747,443.21 | 245,132,791.14 | 256,804,677.98 |
| 非流动负债: | | | | |
| 租赁负债 | 3,760,668.04 | 4,360,388.81 | 5,432,333.56 | 10,057,287.22 |
| 预计负债 | 31,246,034.77 | 36,675,517.36 | 28,661,444.36 | 26,040,926.85 |
| 递延收益 | 40,616,377.04 | 45,422,914.25 | 46,169,134.71 | 46,935,950.64 |
| 递延所得税负债 | 405,057.39 | 16,230,726.54 | 15,300,660.41 | 13,391,884.55 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 76,028,137.24 | 102,689,546.96 | 95,563,573.04 | 96,426,049.26 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 479,685,751.45 | 447,436,990.17 | 340,696,364.18 | 353,230,727.24 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 406,800,000 | 406,800,000 | 406,800,000 | 406,800,000 |
| 资本公积 | 397,038,962 | 397,038,962 | 397,038,962 | 397,038,962 |
| 盈余公积 | 117,548,442.81 | 72,963,779.06 | 72,963,779.06 | 72,963,779.06 |
| 未分配利润 | 955,013,937.91 | 813,055,548.25 | 646,328,000.01 | 614,970,718.03 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,876,401,342.72 | 1,689,858,289.31 | 1,523,130,741.07 | 1,491,773,459.09 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,876,401,342.72 | 1,689,858,289.31 | 1,523,130,741.07 | 1,491,773,459.09 |
| 负债和股东权益合计 | 2,356,087,094.17 | 2,137,295,279.48 | 1,863,827,105.25 | 1,845,004,186.33 |
| 公告日期 | 2024-03-29 | 2023-10-20 | 2023-08-18 | 2023-04-25 |
| 审计意见(境内) | 标准无保留意见 | | | |